BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients and to promote efficiency in the health sector.
The company’s developments include a test to diagnose and monitor acute kidney damage.
- Cell biology
- Collectins and related products
- Cytokines and hormones
- Marker molecules
- Sera and antigens
- Immunoassays APC-PCI ELISA kit
- MBL oligomer ELISA kit
- NGAL ELISA kit
Link to Bioporto